Dog | Signalment | Weight (kg) | ADAMTS-10 Genotype (Phenotype) | AAV | Topical Steroid Treatment | Duration of Treatment | Description of Hair Coat Abnormalities |
---|---|---|---|---|---|---|---|
1a | 3 years; M Beagle | 12.6 | Wildtype (normal) | OS | Difluprednate OU BID | 764 days | Mild periocular alopecia OU |
2 | 2 years; M Beagle | 17.6 | Homozygous mutant (OAG-affected) | OU | Difluprednate OU BID | 102 days | None |
3a | 5 years; M Beagle | 13.6 | Homozygous mutant (OAG-affected) | OS | Difluprednate OU TID | 1164 days | Generalized hypotrichosis and mild periocular alopecia OU |
4 | 5 years; M Beagle | 14.3 | Homozygous mutant (OAG-affected) | OU | Difluprednate OU BID | 102 days | None |
5 | 2 years; F Beagle | 10.3 | Wildtype (normal) | OD | Difluprednate OD BID | 667 days | Periocular alopecia OD |
6 | 4 years; F Beagle | 9.6 | Homozygous mutant (OAG-affected) | OD | Difluprednate OD BID | 764 days | Periocular alopecia OD and pinna alopecia AU |
7 | 4 years; F Beagle | 9.75 | Homozygous mutant (OAG-affected) | OS | Difluprednate OS BID | 764 days | Periocular alopecia OS, pinna alopecia AS, left palmar metacarpal alopecia |
8 | 1.5 years; F Beagle | 13.85 | Homozygous mutant (OAG-affected) | OD | Difluprednate OU TID | 102 days | None |
9 | 1.5 years; M Beagle | 11.8 | Homozygous mutant (OAG-affected) | OS | Difluprednate OU TID | 102 days | None |
10 | 4 years; MN Beagle | 12.6 | Homozygous mutant (OAG-affected) | OU | None | N/A | None |
11 | 4 years; F Beagle | 10.8 | Homozygous mutant (OAG-affected) | OU | None | N/A | None |
12 | 3 years; F Beagle | 12.25 | Carrier (normal) | – | None | N/A | None |
13 | 3 years; M Beagle | 12.6 | Wildtype (normal) | – | None | N/A | None |
14 | 7 years; FS Chihuahua | 5.5 | Wildtype (normal) | – | Difluprednate OU BID | 413 days | Generalized hypotrichosis |